期刊文献+

经尿道等离子腔内剜除术与切除术治疗前列腺增生 被引量:6

PKEK and PKRP treatment for high-risk benign prostatic hyperplasia via urethra
下载PDF
导出
摘要 目的:对比分析经尿道双极等离子前列腺剜除术(PKEP)和前列腺切除术(PKRP)治疗高危良性前列腺增生患者的疗效和安全性。方法:回顾性分析2007年6月至2009年9月共收治高危良性前列腺增生症患者112例,随机分为PKEP组和PKRP组治疗,比较2组患者手术时间、术中出血量、切除组织量、术后尿失禁数和术后住院时间。结果:除住院时间外,2组患者手术时间、术中出血量、切除组织量、术后尿失禁数差异明显,均具有统计学意义(P<0.05),而2组患者术后RUVI、PSS、QOL、Qmax比较差异无统计学意义(P>0.05)。结论:2种术式治疗高危良性前列腺增生症患者均疗效满意,但PKEP在手术时间、术中出血量、切除组织量、术后并发症方面更具优势,值得推广。 Objective: To compare the efficacy and safety of high risk benign prostatic hyperplasia treated with bipolar plasmakinetic resection and bipolar plasmakinetic enucleation via urethra.Methods: 112 cases of high risk benign prostatic hyperplasia were analyzed retrospectively from June,2007 to Sept.2009,which were randomly divided into PKRP group and PKEP group.The operative time,the blood lose,the resected tissue weight,the rate of incontinence of urine and the post-operation hospital stay were compared between two groups.Results: Besides post-operation hospital stay,the operative time,the blood lose,the resected tissue weight and the rate of incontinence of urine were significant different between two groups,which existed statistically significance(P0.05),but there was no significant difference in post-operative RUV,IPSS,QOL,Qmax between two groups(P0.05).Conclusion: The two surgical procedures have the same significant efficacy in the treatment of high risk benign prostatic hyperplasia,but the operative time,blood lose,the resected tissue weight,the rate of incontinence of urine of PKEP are superior to those of PKRP,and it is worth promoting.
出处 《河南大学学报(医学版)》 CAS 2010年第4期283-285,共3页 Journal of Henan University:Medical Science
关键词 前列腺增生症 高危 双极等离子体前列腺切除术 双极等离子体前列腺剜除术 Benign prostatic hyperplasia High risk Bipolar plasmakinetic enucleation Bipolar plasmakinetic resection
  • 相关文献

参考文献7

二级参考文献18

共引文献145

同被引文献60

  • 1顾方六.前列腺增生流行病学和自然史//郭应禄.前列腺增生及前列腺癌.北京:人民卫生出版社,1998:25-30. 被引量:3
  • 2张祥华,王行环,王刚,等.良性前列腺增生诊断治疗指南//那彦群,孙光.中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2009:103-119. 被引量:8
  • 3Rowhrborm CG,McConnell JD.“Etiology,pathophysiology,epidemiology and natural history of benign prostatic hyperplasia.” In:Campbell's Urology.Edited by PC Walsh,AB Retik,ED Vaughan,Jr.Philadelphia,PA:W.B.Saunders Company,2002 chapt 38:1297-1330. 被引量:1
  • 4Berry SJ,Coffey DS,Walsh PC,et al.The development of human benign prostatic hyperplasia with age.J Urol,1984,132(3):474-478. 被引量:1
  • 5Christensen MM,Bruskewitz RC.Clinical manifestations of benign prostatic hyperplasia and the indications for therapeutic intervention.Urol Clin North Am,1990,17(3):509-516. 被引量:1
  • 6彭轼平,良性前列腺增生概论.见:吴阶平,主编.吴阶平泌尿外科学.第1版.山东:山东科学技术出版社,2009:1137. 被引量:2
  • 7Homma Y,Kawabe K,Tsukamoto T,et al.Epidemiologic survey of lower urinary tract symptoms in Asia Australia using the International Prostate Symptom Score.Int Urol,1997,4(1):40-46. 被引量:1
  • 8Ramsey EW.Benign prostatic hyperplasia:a review.Can J Urol,2000,7(6):1135-1143. 被引量:1
  • 9Kramolowsky EV,Tucker RD.Use of 5F bipolar electrosurgical probe in endoscopic urological procedures.J Urol,1990,143(2):275-277. 被引量:1
  • 10Botto H,Lebret T,Barre P,et al.Electrovaporization of prostate with the Gyrus Device.J Endourology,2001,15(3):313-316. 被引量:1

引证文献6

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部